ArticleClinical journal of the American Society of Nephrology : CJASN2020

Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan.

Matteo Bargagli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.